SCHEMBL1760587

SCHEMBL1760587

COC(=O)c1nccnc1N1CCSCC1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.39
MEN1 O00255 1/20 0.39
PKM P14618 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.36
MTOR P42345 2/20 0.36
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK10 P53779 1/20 0.35
HSD17B10 Q99714 1/20 0.35
OPRK1 P41145 4/20 0.34
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP3A4 P08684 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
MAPT P10636 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3891024 0.86 L3MBTL1 (0.43) L3MBTL1MEN1KMT2ANPSR1ALDH1A1
SCHEMBL1760423 0.81 ALDH1A1 (0.41) L3MBTL1MEN1PKMKMT2ANPSR1
SCHEMBL394318 0.78 OPRK1 (0.54) L3MBTL1MEN1KMT2ANPSR1OPRK1
SCHEMBL26394011 0.77 L3MBTL1 (0.39) L3MBTL1NPSR1OPRK1KDM4E
SCHEMBL2348152 0.74 ALDH1A1 (0.48) L3MBTL1KMT2ANPSR1ALDH1A1ALOX15
SCHEMBL9493845 0.73 ADRA2A (0.43) MEN1KMT2ANPSR1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL9493835 0.72 ADRA2A (0.42) L3MBTL1MEN1KMT2ANPSR1ALDH1A1
SCHEMBL71518 0.72 NPSR1 (0.59) L3MBTL1NPSR1ALDH1A1KDM4EMAPT
SCHEMBL15714879 0.70 MYC (0.49) L3MBTL1PKMNPSR1ALDH1A1HSD17B10
SCHEMBL18744958 0.68 RAB9A (0.67) L3MBTL1MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499121-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS. F. Hoffmann-La Roche AG (CH) 2012-09-19 EP disclosed
WO-2011057973-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2011-05-19 WO disclosed